Delivering DNA and RNA Vaccines Where and How They Are Needed.
INTRODUCING ORLANCE MACH-1 ™
Orlance aims to deliver powdered, needle-free, shelf-stable, nucleic acid vaccines (DNA and/or RNA) with its epidermal vaccine delivery platform.
World Vaccine Congress, Barcelona29 to 31 October, 2024.
BIO Investor Forum, San Francisco15 to 16 October, 2024.
Society for Immunotherapy of Cancer, Houston6 to 10 November, 2024.
Thank you for your interest in joining the Orlance team. While we currently do not have any openings, please check again another time.
kaalto@orlance.com / info@orlance.com